The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases

Pharmacol Res. 2020 Mar:153:104676. doi: 10.1016/j.phrs.2020.104676. Epub 2020 Jan 30.

Abstract

Phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent Rac exchanger 1 (P-Rex1) is a guanine nucleotide exchange factor (GEF) for Rac small GTPases and the Rac-related GTPase RhoG. P-Rex1 plays an important role in cell migration and relays intracellular signals generated through activation of G protein-coupled receptors and receptor tyrosine kinases. Studies of mouse models have found that P-Rex1 expression and activation is associated with tumor cell migration, brain development and pathological changes such as lung edema. Since its initial discovery, P-Rex1 has been known for its large size and multiple activation mechanisms that involve not only PIP3 but also the βγ subunits of heterotrimeric G proteins and a regulatory subunit of cyclic AMP-dependent kinase, PKA RIα. At the core of the GEF activity is the tandem Dbl homology domain and the pleckstrin homology domain (DH/PH domains) that are masked until activation signals unwind the P-Rex1 structure. Understanding the activation mechanisms will help designing therapeutics that target P-Rex1 for cancer and other diseases.

Keywords: Cancer metastasis; Guanine nucleotide exchange factor; Inflammatory diseases; Small GTPase.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Movement / genetics*
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / metabolism*
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism*
  • Inflammation / pathology
  • Molecular Targeted Therapy
  • Neoplasm Metastasis
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Protein Transport

Substances

  • Guanine Nucleotide Exchange Factors
  • PREX1 protein, human